Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers,brain-boosting yogurts.
Michael Winter
Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers, brain-boosting yogurts, sports nutrition, baby food and bone supplement drinks, is poised to take off globally.
With consumers becoming ever more health-aware and knowledgeable, companies from both the pharma and consumer segments are competing hard to get a piece of the action.
Which players will successfully harness the segment’s potential? Whatever the outcome of the battle, talent will be a critical weapon, as interviews with C-suite executives from top food, personal care and OTC drug companies have recently shown.
The war for talent between pharma and consumer players looks set to be intense, with both sides keen - and ever more active - to lure away senior talent from their competitors to plug competence gaps and boost their own executive bench strength. This is easier said than done. Finding, attracting, convincing, and integrating this talent can be tough. It takes courage and vision for companies to move away from familiar territory and recruit a new breed of leader.
Top consumer health leaders tend to display four exceptional competency spikes.
Finding executives who meet these criteria is an issue facing consumer health businesses. In some cases they may need to take a lateral view of the talent pool, perhaps even looking to other sectors to find high-calibre leaders with the right profile.
Recruiting this kind of leadership talent, however, is merely the first step. Effective onboarding is absolutely essential. This involves companies making a serious commitment to integrating new talent. Only those companies that are truly committed to consumer health, have a clear vision and are ready to make a serious investment will attract outstanding talent that transcends the respective legacies of the pharma and consumer industries.
Michael Winter is a consultant with executive search and advisory firm Egon Zehnder.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.